WallStSmart

CRH PLC (CRH)vsCemex SAB de CV ADR (CX)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

CRH PLC generates 124% more annual revenue ($38.96B vs $17.38B). CRH leads profitability with a 9.2% profit margin vs 3.6%. CX appears more attractively valued with a PEG of 0.39. CX earns a higher WallStSmart Score of 67/100 (B-).

CRH

Buy

55

out of 100

Grade: C-

Growth: 3.3Profit: 7.0Value: 4.7Quality: 6.0
Piotroski: 5/9Altman Z: 2.17

CX

Strong Buy

67

out of 100

Grade: B-

Growth: 6.7Profit: 5.0Value: 6.7Quality: 4.5
Piotroski: 4/9Altman Z: 1.48
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRHSignificantly Overvalued (-56.4%)

Margin of Safety

-56.4%

Fair Value

$60.61

Current Price

$94.81

$34.20 premium

UndervaluedFair: $60.61Overvalued
CXUndervalued (+20.3%)

Margin of Safety

+20.3%

Fair Value

$13.59

Current Price

$10.72

$2.87 discount

UndervaluedFair: $13.59Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRH4 strengths · Avg: 8.3/10
Market CapQuality
$60.41B9/10

Large-cap with strong market position

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.17B8/10

Generating 1.2B in free cash flow

CX3 strengths · Avg: 10.0/10
PEG RatioValuation
0.3910/10

Growing faster than its price suggests

Price/BookValuation
1.3x10/10

Reasonable price relative to book value

EPS GrowthGrowth
57.7%10/10

Earnings expanding 57.7% YoY

Areas to Watch

CRH3 concerns · Avg: 3.3/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Revenue GrowthGrowth
3.0%4/10

3.0% revenue growth

EPS GrowthGrowth
-15.8%2/10

Earnings declined 15.8%

CX4 concerns · Avg: 2.5/10
Return on EquityProfitability
3.9%3/10

ROE of 3.9% — below average capital efficiency

Profit MarginProfitability
3.6%3/10

3.6% margin — thin

P/E RatioValuation
65.8x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.482/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CRH

The strongest argument for CRH centers on Market Cap, P/E Ratio, Price/Book.

Bull Case : CX

The strongest argument for CX centers on PEG Ratio, Price/Book, EPS Growth. PEG of 0.39 suggests the stock is reasonably priced for its growth.

Bear Case : CRH

The primary concerns for CRH are PEG Ratio, Revenue Growth, EPS Growth.

Bear Case : CX

The primary concerns for CX are Return on Equity, Profit Margin, P/E Ratio. A P/E of 65.8x leaves little room for execution misses. Thin 3.6% margins leave little buffer for downturns.

Key Dynamics to Monitor

CRH carries more volatility with a beta of 1.19 — expect wider price swings.

CX is growing revenue faster at 8.1% — sustainability is the question.

CRH generates stronger free cash flow (1.2B), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CX scores higher overall (67/100 vs 55/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CRH PLC

BASIC MATERIALS · BUILDING MATERIALS · USA

CRH plc manufactures and distributes construction materials. The company is headquartered in Dublin, Ireland.

Visit Website →

Cemex SAB de CV ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

CEMEX, SAB de CV, produces, markets, distributes and sells cement, ready-mix concrete, aggregates, clinker and other construction materials worldwide. The company is headquartered in San Pedro Garza Garca, Mexico.

Want to dig deeper into these stocks?